why choose us

First received: September 27, 2022

Clinical Trial: Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Malignant Solid Neoplasm

Study Type: INTERVENTIONAL


Official Title: Molecular Analysis for Combination Therapy Choice (ComboMATCH)

Brief Summary: This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing.Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials.Genetic tests look at the unique…

Read more